跳至主要内容
临床试验/NCT02372786
NCT02372786已完成4 期

A Double Blind Randomized Controlled Trial Comparing the Efficacy of 7% Lidocaine / 7% Tetracaine Cream Versus 2,5% Lidocaine / 2,5% Prilocaine Cream for Local Anaesthesia During Laser Treatment of Acne Keloidalis Nuchae and Tattoo Removal

Erasmus Medical Center1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2014年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
30
试验地点
1
主要终点
Self-reported pain (10 point visual analog scale).

研究概览

简要总结

The purpose of this study is to compare the efficacy of 7% lidocaine / 7% tetracaine cream and 2,5% lidocaine / 2,5% prilocaine cream in reducing self-reported pain during a single laser procedure in the treatment of acne keloidalis nuchae and tattoo removal.

详细描述

In this study we will compare the efficacy of 7% lidocaine / 7% tetracaine cream and 2,5% lidocaine / 2,5% prilocaine cream in reducing self-reported pain during a single laser procedure in the treatment of acne keloidalis nuchae and tattoo removal. Patients will be asked to fill in questionnaires to:

  • assess the severity of pain experienced (VAS score) during laser treatment,
  • evaluate whether the pain relief is adequate and,
  • evaluate the amount of money patients would be willing to pay for the cream that provided the 'best' pain relief.

One week after the visit the patient will have a telephone consultation. The patients will be asked if they experienced any symptoms, which will be recorded as adverse events.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Subject has provided written informed consent;
  • Subject is ≥ 18 years of age at time of screening;
  • Group A: subjects with acne keloidalis nuchae;
  • Group B: subjects with an uniform, black, professionally placed tattoo

排除标准

  • • Known sensitivity to any components of the test materials;
  • Pregnant or breast-feeding women;
  • Use of any other pain medication during past 24 hours prior to the laser treatment;
  • Damaged skin at the designated treatment site;
  • Blister formation and/or scar formation after test-treatment with standard laser settings;
  • Any medical or psychiatric condition which, in the investigator's opinion, would preclude the participant from adhering to the protocol or completing the study per protocol.

研究组 & 干预措施

Acne Keloidalis Nuchae

Other

2,5% lidocaine / 2,5% prilocaine cream and 7% lidocaine / 7% tetracaine cream will be applied for 60 minutes. After removal of the creams patients will recieve laser hair removal treatment using a neodymium-doped yttrium aluminium garnet (Nd:Yag) laser.

干预措施: 2,5% lidocaine / 2,5% prilocaine cream (Drug)

Acne Keloidalis Nuchae

Other

2,5% lidocaine / 2,5% prilocaine cream and 7% lidocaine / 7% tetracaine cream will be applied for 60 minutes. After removal of the creams patients will recieve laser hair removal treatment using a neodymium-doped yttrium aluminium garnet (Nd:Yag) laser.

干预措施: 7% lidocaine / 7% tetracaine cream (Drug)

Tattoo

Other

2,5% lidocaine / 2,5% prilocaine cream and 7% lidocaine / 7% tetracaine cream will be applied for 60 minutes. After removal of the creams patients will recieve laser tattoo removal treatment using a Q-switched nd Yag laser.

干预措施: 2,5% lidocaine / 2,5% prilocaine cream (Drug)

Tattoo

Other

2,5% lidocaine / 2,5% prilocaine cream and 7% lidocaine / 7% tetracaine cream will be applied for 60 minutes. After removal of the creams patients will recieve laser tattoo removal treatment using a Q-switched nd Yag laser.

干预措施: 7% lidocaine / 7% tetracaine cream (Drug)

Tattoo

Other

2,5% lidocaine / 2,5% prilocaine cream and 7% lidocaine / 7% tetracaine cream will be applied for 60 minutes. After removal of the creams patients will recieve laser tattoo removal treatment using a Q-switched nd Yag laser.

干预措施: Q-switched nd Yag laser (Device)

结局指标

主要结局

Self-reported pain (10 point visual analog scale).

时间窗: 5 minutes

次要结局

  • willing to spend around 25 euro for best pain relief (yes/no).(10 minutes)
  • adequate pain relief (yes/no);(10 minutes)
  • To monitor the nature and frequency of adverse events(one week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

M.B.A. van Doorn

MD, PhD

Erasmus Medical Center

研究点 (1)

Loading locations...

相似试验